Titlebook: Emerging Targets in Antibacterial and Antifungal Chemotherapy; Joyce A. Sutcliffe,Nafsika H. Georgopapadakou Book 1992 Routledge, Chapman

BROW

Interrupt Handling Architectures,d type II based on their ability to catalyse single- or double-strand cleavages, respectively; in addition type II enzymes have an energy requirement satisfied by ATP. In bacteria, topoisomerase II is often referred to as bacterial gyrase. . contains two type I topoisomerases, the TopA and TopB prot

受人支配

ethnology

異教徒

Emg827

蝕刻術

Emerging Targets in Antibacterial and Antifungal Chemotherapy

APEX

Emerging Targets in Antibacterial and Antifungal Chemotherapy978-1-4615-3274-3

天然熱噴泉

Recess

ESPY

Historical Perspectives of Approaches to Antibiotics Discoveryntibiotics, however, declined, sharply thereafter, precipitating strategic changes. Mechanism-based or target-directed screening, utilization of rare microorganisms and unusual culture conditions, and introduction of gene technology to modify antibiotic productivity have been among the major changes